Medra builds a platform that speeds scientific research by automating lab work with AI and robotics. Its Continuous Science Platform has two parts: Physical AI, which uses general-purpose robots to perform lab tasks (like pipetting and handling samples) and connect with standard instruments, and Scientific AI, which analyzes experimental data to find patterns and suggest new experiments, creating a closed loop that learns from results. Scientists can give workflows in natural language, and the system runs experiments at a larger scale and faster pace than manual work. Medra differentiates itself by tightly integrating flexible robotic automation with AI-driven experiment design in a continuous feedback loop, supported by partnerships with biopharma and research organizations. Its goal is to remove data bottlenecks in biology and drug discovery by enabling rapid, high-throughput, automated laboratories.
Company Size
51-200
Company Stage
Series A
Total Funding
$63M
Headquarters
San Francisco, California
Founded
2021
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?